Avalo, Inc.

Biotechnology company · Durham, North Carolina, United States

Avalo, Inc. is a biotechnology company headquartered in Durham, North Carolina, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $500,000 sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

Avalo at a glance

Typebiotechnology company

HeadquartersDurham, North Carolina, United States

Earliest incorporation on record2020

SEC CIK1875179

What does Avalo do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $500,000 sold (2022).

Frequently asked questions about Avalo

Where is Avalo headquartered?

Avalo, Inc. is headquartered in Durham, North Carolina, United States.

What does Avalo do?

Avalo, Inc. is a biotechnology company.

When was Avalo founded?

The earliest incorporation on record for Avalo, Inc. is in 2020, according to public company registers.

Similar companies

Humacyte, Inc.Durham, North Carolina, United States
Precision Biosciences IncDurham, North Carolina, United States
Xilis, Inc.Durham, North Carolina, United States
inSoma Bio, Inc.Durham, North Carolina, United States
Atsena Therapeutics, Inc.Durham, North Carolina, United States
Scion Neurostim, Inc.Durham, North Carolina, United States
Sapere Bio, Inc.Durham, North Carolina, United States
BioAesthetics CorpDurham, North Carolina, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences